Substance-induced psychosis: A diagnostic conundrum

被引:80
作者
Mathias, Steve
Lubman, Dan I.
Hides, Leanne
机构
[1] ORYGEN Res Ctr, Dept Psychiat, Parkville, Vic, Australia
[2] Univ Melbourne, Melbourne, Vic, Australia
关键词
D O I
10.4088/JCP.v69n0304
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Objective: To critically examine the DSM-IV-TR criteria for substance-induced psychotic disorder (SIPD). Data Sources: Leading electronic databases (such as MEDLINE, PubMed) were searched for the years 1992 through 2007, using combinations of the following key search terms: substance abuse/dependence, alcohol, marijuana, cannabis, methamphetamine, crack, cocaine, amphetamine, ecstasy, ketamine, phencyclidine, LSD, mental health, drug-induced psychosis, substance-induced psychosis, psychosis, and schizophrenia. References identified from bibliographies of pertinent articles and books in the field were also collected and reviewed. Data Extraction: Only research studies or case reports/series that. presented data on populations diagnosed with SIPD by using clinical or structured diagnostic interviews and that were published in English were used to assess the validity of the current SIPD criteria. Data Synthesis: We identified 49 articles that presented clinical data on SIPD. Almost half of these publications were case reports, with 18 articles specifically focusing on delineating the clinical characteristics or outcomes of individuals diagnosed with SIPD. While several large studies have recently been conducted to assess the stability of SIPD, there is a dearth of research that rigorously examines the validity of DSM-IV diagnostic criteria across substances. Conclusions: There remains a striking paucity of information on the outcome, treatment, and best practice for substance-associated psychotic episodes. Further work is clearly required before the advent of DSM-V. We propose an alternative, broader classification that better reflects the current evidence base, inferring association rather than causation.
引用
收藏
页码:358 / 367
页数:11
相关论文
共 71 条
  • [1] Longitudinal clinical course following pharmacological treatment of methamphetamine psychosis which persists after long-term abstinence
    Akiyama, Kazufumi
    [J]. CELLULAR AND MOLECULAR MECHANISMS OF DRUGS OF ABUSE AND NEUROTOXICITY: COCAINE, GHB, AND SUBSTITUTED AMPHETAMINES, 2006, 1074 : 125 - 134
  • [2] Alem A, 1997, ETHIOPIAN MED J, V35, P137
  • [3] American Psychiatric Association, 1994, DSM 4 SOURC, V1
  • [4] American Psychiatric Association, 2000, Text revision (DSM-IV-TR), DOI [10.1176/dsm10.1176/appi.books.9780890420249.dsm-iv-tr, DOI 10.1176/DSM10.1176/APPI.BOOKS.9780890420249.DSM-IV-TR]
  • [5] [Anonymous], 2006, ANN REP 2006 STAT DR
  • [6] Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases
    Arendt, M
    Rosenberg, R
    Foldager, L
    Perto, G
    Munk-Jorgensen, P
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 2005, 187 : 510 - 515
  • [7] Causal association between cannabis and psychosis: examination of the evidence
    Arseneault, L
    Cannon, M
    Witton, J
    Murray, RM
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 2004, 184 : 110 - 117
  • [8] *AUSTR I HLTH WELF, 2005, DRUG STAT SERIES, V13
  • [9] Quantitative drug levels in stimulant psychosis: Relationship to symptom severity, catecholamines and hyperkinesia
    Batki, SL
    Harris, DS
    [J]. AMERICAN JOURNAL ON ADDICTIONS, 2004, 13 (05) : 461 - 470
  • [10] A comparison of olanzapine with haloperidol in cannabis-induced psychotic disorder: a double-blind randomized controlled trial
    Berk, M
    Brook, S
    Trandafir, AI
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1999, 14 (03) : 177 - 180